Clinical Trials

Sponsor: NRG

Sponsor Study ID: NRG-GU013

Study Title: NRG-GU013: THE PHASE III HIGH FIVE TRIAL FIVE FRACTION RADIATION FOR HIGH-RISK PROSTATE CANCER

CTO #: 104197

NCT Number:

Phase: III

Protocol Type: Treatment

Age Group: Adults

Disease Sites: Prostate

Study Objectives:



Study Documents    
(MUSC NetID required for document access)